My research interests focus on the study of chronic liver disease and primary liver cancer, particularly from nonalcoholic fatty liver disease (NAFLD). As part of the NAFLD Research Team at Duke, I am investigating the role of epigenetics and genetics on the development of advanced fibrosis from NAFLD. The long term goal of our research is to develop non-invasive biomarkers to identify those patients at increased risk for cirrhosis and end stage liver disease in order to risk stratify patients as well as to develop better preventative and therapeutic strategies.
Education and Training
- Fellow in Gastroenterology, Medicine, Duke University, 2005 - 2009
- Resident, Medicine, Duke University, 2002 - 2005
- M.D., University of Miami, 2002
- A multidisciplinary study of biological disparities in NASH progression and response to statins to inform personalized liver cancer chemoprevention in NAFLD
- Is Heart Failure with Preserved Edection Fraction the Symptomatic Manifestation of Liver Disease
- Hepatocellular Carcinoma, Epigenetics and Cadmium Exposure